+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Testing Market - Global Forecast 2026-2032- Product Image
Nucleic Acid Testing Market - Global Forecast 2026-2032- Product Image
New

Nucleic Acid Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968571
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nucleic acid testing market is evolving swiftly, reshaping clinical and operational decision-making for healthcare and life sciences organizations worldwide. As transformation accelerates, senior leaders must anticipate shifts in technology, supply chain, and regulatory dynamics to remain competitive in this critical diagnostics segment.

Market Snapshot: Nucleic Acid Testing Market Size and Growth

The Nucleic Acid Testing Market was valued at USD 10.47 billion in 2025 and is projected to reach USD 11.33 billion in 2026, with a compound annual growth rate (CAGR) of 9.50%, attaining USD 19.77 billion by 2032. Market momentum is underpinned by the adoption of innovative assay systems, integration of digital informatics platforms, and evolving global supply strategies. Senior decision-makers in diagnostics, life sciences, and procurement should recognize how these drivers are reshaping operational models. Ongoing convergence of automation and analytics streamlines workflows, delivering increased throughput and robust data fidelity. As investment strategies adjust, technology providers see growing demand for adaptable solutions and collaborative partnerships across laboratory and clinical networks.

Nucleic Acid Testing Market Scope & Segmentation

  • Product Types: Instruments form the cornerstone of capital procurement cycles and are fundamental to infrastructure planning. Reagents and kits, with their recurring use, create predictable supply needs and impact supplier relationships. Software and services direct workflow automation, ensuring data integrity and linking analytical outputs to reporting.
  • Technology Types: Digital PCR, isothermal amplification, next-generation sequencing, real-time PCR, and microarray technologies enable a broad range of molecular diagnostics, from rapid, high-sensitivity detection to diverse genomic analysis.
  • Sample Matrices: Blood, saliva, swabs, tissue, and urine samples are central to clinical and research workflows, each requiring distinct protocols for extraction, handling, and sample validation. Non-invasive matrices expand testing reach, while robust controls underpin reliability for complex sample types.
  • Applications: Clinical diagnostics, research, drug discovery, forensics, and veterinary diagnostics span diverse use cases that demand tailored performance criteria, compliance pathways, and validation processes.
  • End-User Profiles: Academic institutes, diagnostic laboratories, hospitals and clinics, as well as pharmaceutical and biotechnology companies, dictate procurement patterns based on throughput targets, technical needs, and infrastructure compatibility.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific each introduce unique regulatory, manufacturing, and adoption frameworks, necessitating regionalized market approaches and stakeholder engagement.

Key Takeaways for Senior Decision-Makers

  • The market is trending toward decentralized and modular molecular diagnostics, increasing access and accelerating decision timelines outside centralized labs.
  • Cloud-native bioinformatics and integrated digital workflows are transforming real-time analytics, supporting seamless interoperability across research and clinical environments.
  • Validated, kit-based processes and reagent bundling are streamlining complex assay rollouts, optimizing procurement, and enhancing uniformity in multicenter and high-throughput deployments.
  • Recent policy measures, such as tariffs, have prompted organizations to diversify sourcing, develop regional assembly capabilities, and negotiate supplier contracts that support agility and supply resilience.
  • Differing regional regulatory demands and reimbursement structures require customized strategies, emphasizing the importance of local partnerships for sustainable market entry and continued adoption.
  • Collaboration between established vendors and emerging firms is driving platform integration, reinforcing recurring revenue models and strengthening customer engagement through joint validation initiatives.

Tariff Impact: Strategic Supply Chain Adjustments

The introduction of tariffs and related policy updates in 2025 added new complexity to the nucleic acid testing value chain. Increased import duties on key laboratory instruments and consumables led to a reassessment of sourcing strategies. Many companies are transitioning toward nearshoring, dual sourcing, and regionally based assembly models to limit exposure and enhance agility. As a result, procurement teams now seek product designs that are modular and locally adaptable, while supplier negotiations increasingly emphasize stable pricing structures and operating continuity in response to shifting regulatory requirements.

Research Methodology & Data Sources

This analysis draws on structured primary interviews with key stakeholders, supported by in-depth secondary research of peer-reviewed studies, technical documentation, and prevailing regulatory standards. All findings undergo rigorous cross-validation using standardized evaluation methodologies to assure accuracy, consistency, and transparency throughout the report.

Why This Report Matters

  • Enables leaders to benchmark investments and refine their approaches with actionable insights on segments, products, and technologies—supporting evidence-driven strategy development.
  • Equips procurement and R&D teams to anticipate regulatory shifts and global supply adaptations, increasing confidence in navigating operational complexity.
  • Offers an integrated perspective on how operational, financial, and clinical drivers intersect to influence competitiveness and adoption in the nucleic acid testing sector.

Conclusion

Nucleic acid testing is at a strategic inflection point. Organizations that balance innovation with supply chain resilience and validation excellence are best positioned to strengthen their market standing and respond effectively to evolving clinical priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Nucleic Acid Testing Market, by Product Type
8.1. Instruments
8.2. Reagents & Kits
8.3. Software & Services
9. Nucleic Acid Testing Market, by Technology
9.1. Digital PCR
9.2. Isothermal Amplification
9.3. Microarray
9.4. Next Generation Sequencing
9.5. Real Time PCR
10. Nucleic Acid Testing Market, by Sample Type
10.1. Blood
10.2. Saliva
10.3. Swabs
10.4. Tissue
10.5. Urine
11. Nucleic Acid Testing Market, by Application
11.1. Clinical Diagnostics
11.2. Drug Discovery
11.3. Forensics
11.4. Research
11.5. Veterinary Diagnostics
12. Nucleic Acid Testing Market, by End User
12.1. Academic Research Institutes
12.2. Diagnostic Laboratories
12.3. Hospitals & Clinics
12.4. Pharmaceutical & Biotechnology Companies
13. Nucleic Acid Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Nucleic Acid Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Nucleic Acid Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Nucleic Acid Testing Market
17. China Nucleic Acid Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Agilent Technologies, Inc.
18.7. Becton, Dickinson and Company
18.8. Bio-Rad Laboratories, Inc.
18.9. bioMérieux SA
18.10. Danaher Corporation
18.11. F. Hoffmann-La Roche Ltd.
18.12. Hologic, Inc.
18.13. Illumina, Inc.
18.14. PerkinElmer, Inc.
18.15. QIAGEN N.V.
18.16. Quest Diagnostics Incorporated
18.17. Seegene Inc.
18.18. Siemens Healthineers AG
18.19. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SWABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SWABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SWABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY VETERINARY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 114. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. ASEAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. GCC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GCC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. GCC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. GCC NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 133. GCC NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. GCC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 145. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. BRICS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. G7 NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. G7 NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. G7 NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. G7 NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 151. G7 NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. G7 NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. NATO NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. NATO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. NATO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. NATO NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 157. NATO NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. NATO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. CHINA NUCLEIC ACID TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 167. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 170. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Nucleic Acid Testing market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.77 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2025-2033 - Product Image

Nucleic Acid Testing Market Report by Product Type, Technology, End User, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Nucleic Acid Testing - Global Strategic Business Report - Product Image

Nucleic Acid Testing - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
2025 Czechia Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks - Product Image

2025 Czechia Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks

  • Report
  • 1120 Pages
  • Global
From
2025 Global Nucleic Acid Testing (NAT) Market Opportunities in the US, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks - Product Image

2025 Global Nucleic Acid Testing (NAT) Market Opportunities in the US, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious - Latest Technologies, Market Barriers and Risks

  • Report
  • 1170 Pages
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
2025 Global Forecast for Trichomonas Vaginalis Nucleic Acid Test Kit Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Trichomonas Vaginalis Nucleic Acid Test Kit Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the NAT Screening Market

The NAT Screening market within the context of In Vitro Diagnostics is a segment of the healthcare industry that focuses on the development and commercialization of tests that detect the presence of infectious agents in a sample. These tests are used to diagnose and monitor the spread of infectious diseases, such as HIV, hepatitis, and other viruses. NAT Screening tests are used in a variety of settings, including clinical laboratories, hospitals, and public health departments. NAT Screening tests are typically performed using a variety of technologies, such as polymerase chain reaction (PCR), nucleic acid hybridization, and enzyme-linked immunosorbent assays (ELISA). These tests are used to detect the presence of specific genetic material in a sample, which can be used to identify the presence of a particular infectious agent. Some companies in the NAT Screening market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.